Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Twist Bioscience Corp at Cowen Health Care Conference Transcript

Mar 12, 2019 / 03:20PM GMT
Release Date Price: €18.93 (-0.94%)
Doug Schenkel
Cowen and Company - Analyst

All right, good morning. I am Doug Schenkel, one of the healthcare analysts here at Cowen. It's my pleasure to welcome you to this session with Twist Biosciences. From the Company we have Emily Leproust, the Chief Executive Officer. The plan is for Emily to I think use up probably most if not all of the 30 minutes to just walk through the Twist story.

And then, if we have time for a couple questions, maybe we'll do some of them here. But if not, we do have a breakout next door in Salon D where we will have another half an hour to have a pretty interactive discussion. Jim Thorburn, From the Company, the Chief Financial Officer, is here as well. So without further ado, Emily, thanks for being here and let me hand it over to you.

Emily Leproust
Twist Bioscience Corporation - CEO

Thank you very much, Doug, for the invitation and the introduction. It is great to be here. I'll start by saying that I will be making forward-looking statements in the next few slides. For those of you that don't know Twist, we have a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot